1 authorised product containing variant XBB.1.16, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| BIMERVAX XBB.1.16. COVID-19 Vaccine (recombinant, adjuvanted) EU/1/22/1709/005-007 |
SARS-CoV-2, variant XBB.1.16, spike protein, receptor binding domain fusion homodimer | Hipra Human Health S.L. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.